ADA and hyperinsulinemic hypoglycemia, familial, 4: On the other hand, enzyme replacement therapy for ADA SCID, used as a prophylactic therapy while the patient with ADA deficiency awaits HSCT or gene therapy, is the treatment that is less frequently available, with no availability in 33 of the 54 countries that have responded to the question.